Details for New Drug Application (NDA): 020429
✉ Email this page to a colleague
NDA 020429 describes ORUDIS KT, which is a drug marketed by Wyeth Cons and is included in one NDA. Additional details are available on the ORUDIS KT profile page.
The generic ingredient in ORUDIS KT is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
The generic ingredient in ORUDIS KT is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
Summary for 020429
| Tradename: | ORUDIS KT |
| Applicant: | Wyeth Cons |
| Ingredient: | ketoprofen |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020429
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Oct 6, 1995 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
